Speaker(s): 

Cole Walters, PharmD, RPh, – Ambulatory Care Clinical Pharmacist, Geisinger Primary Care, Mifflintown PA - has nothing to disclose.

Moderator(s): 

Adriene K. Zook, PharmD, RPH, - Manager Pharmacy, Geisinger Medication Therapy Disease Management, Danville PA - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Explain the basis for prioritizing blood pressure and lipid management in the diabetes patient, from an ASCVD risk reduction perspective

• Appraise primary literature and guideline recommendations pertaining to the goals and treatments for hypertension and dyslipidemia in the diabetes population

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Marino, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; David Mallarkey, BSN, RN, Jaime Ruiz, RN, BSN, and Joey Underhill have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None